These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prior authorization reform: We are just getting started. Wood D Minn Med; 2015 Jul; 98(7):36. PubMed ID: 26267917 [No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558 [No Abstract] [Full Text] [Related]
7. The new Medicare prescription-drug legislation. Altman DE N Engl J Med; 2004 Jan; 350(1):9-10. PubMed ID: 14702422 [No Abstract] [Full Text] [Related]
9. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435 [No Abstract] [Full Text] [Related]
10. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003. MacEachern L Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004. Seay M Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309 [No Abstract] [Full Text] [Related]
12. The need for health care reform. Mossinghoff GJ Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516 [No Abstract] [Full Text] [Related]
13. Drug insurance for the elderly moves ahead in Congress. Greenberg DS Lancet; 2000 Jul; 356(9223):51. PubMed ID: 10892773 [No Abstract] [Full Text] [Related]
14. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112 [TBL] [Abstract][Full Text] [Related]
15. Pharmaceuticals and medical devices: Medicare Part D. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844 [No Abstract] [Full Text] [Related]
16. Fresh Approaches to Addressing High Drug Costs. Armstrong J; Becker C NCSL Legisbrief; 2019 Apr; 27(15):1-2. PubMed ID: 30990598 [No Abstract] [Full Text] [Related]
17. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance]. Hellmich B; Gross WL Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800 [No Abstract] [Full Text] [Related]
18. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses. Donohue JM Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937 [No Abstract] [Full Text] [Related]
19. Pharmaceuticals and medical devices: Medicare Part D. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447 [No Abstract] [Full Text] [Related]
20. MMA goes head on against medication prior authorization. Hauser D Minn Med; 2015 Mar; 98(3):26-7. PubMed ID: 25876318 [No Abstract] [Full Text] [Related] [Next] [New Search]